Guardian Pharmacy Services, Inc.
Description
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
About
CEO
Mr. Fred P. Burke
Employees
0
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Care Facilities
MIC code
XNYS
Address
300 Galleria Parkway SE, Atlanta, GA 30339, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 13, 2024 | 0.19 | -2.00 | -2.19 | -1,152.63% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 3 | — | 3 |
| Average estimate | — | 0.20 | — | 0.87 |
| Low estimate | — | 0.19 | — | 0.85 |
| High estimate | — | 0.21 | — | 0.88 |
| Last year EPS | — | — | — | 0.84 |
[stock_revenue_estimate]
Growth estimates
Current qtr
—
Next qtr. (Mar 2025)
—
Current year
—
Next year (Dec 2025)
3.180%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | |
|---|---|
| Fiscal date | 2023-12-31 |
| Total reported revenue | 1.05B |
| Cost of revenue | 837.88M |
| Gross profit | 208.31M |
| Operating expense | |
| Research & development | — |
| Selling general and admin | 167.36M |
| Other operating expenses | — |
| Operating income | 40.95M |
| Non operating interest income | |
| Income | — |
| Expense | 2.86M |
| Other income expense | -367,000 |
| Pretax income | 37.72M |
| Tax provision | — |
| Net income | 37.72M |
| Basic EPS | 0.39 |
| Diluted EPS | 0.39 |
| Basic average shares | 60.84M |
| Diluted average shares | 60.84M |
| EBITDA | 58.81M |
| Net income from continuing op. | 37.72M |
| Minority interests | -13.82M |
| Preferred stock dividends | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 271.17M | 256.11M | 235.85M | 217.87M | — |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 752,000 | 607,000 | 15.01M | 6.45M | — |
| Other short term investments | — | — | — | — | — |
| Accounts receivable | 77.26M | 67.83M | 55.25M | 45.78M | — |
| Other receivables | — | — | — | 2.89M | 3.30M |
| Inventory | 36.73M | 41.44M | 33.09M | 31.93M | — |
| Prepaid assets | — | — | — | — | — |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | 508,000 |
| Hedging assets | — | — | — | — | — |
| Other current assets | 14.86M | 10.12M | 8.52M | 6.77M | — |
| Non current assets | |||||
| Properties | 88.62M | 79.28M | 67.25M | 63.75M | — |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | 39.44M | 34.42M | 30.03M | 28.03M | — |
| Construction in progress | — | — | — | — | — |
| Leases | 14.04M | 12.29M | 8.71M | 7.57M | — |
| Accumulated depreciation | -68.92M | -60.80M | -54.26M | -47.38M | — |
| Goodwill | 124.07M | 126.53M | 126.35M | 124.02M | — |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 11.98M | 14.44M | 17.09M | 19.11M | — |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 358,000 | 435,000 | 529,000 | 505,000 | — |
| Total liabilities | 211.31M | 180.19M | 182.53M | 150.80M | — |
| Current liabilities | |||||
| Accounts payable | 85.60M | 78.10M | 64.62M | 53.41M | — |
| Accrued expenses | — | — | — | 7.21M | 5.46M |
| Short term debt | 19.21M | 13.50M | 9.62M | 12.56M | — |
| Deferred revenue | — | — | — | — | — |
| Tax payable | — | — | — | — | — |
| Pensions | 16.96M | 13.95M | 14.57M | 13.18M | — |
| Other current liabilities | 16.25M | 6.45M | 8.73M | — | 438,000 |
| Non current liabilities | |||||
| Long term debt | 41.80M | 43.31M | 40.81M | 46.28M | — |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 31.50M | 24.87M | 2.99M | 3.35M | — |
| Shareholders equity | |||||
| Common stock | — | — | — | — | — |
| Retained earnings | — | — | — | — | — |
| Other shareholders equity | — | — | -185,000 | -676,000 | -630,000 |
| Total shareholders equity | 59.86M | 75.93M | 53.32M | 67.07M | — |
| Additional paid in capital | — | — | — | — | — |
| Treasury stock | — | — | — | — | — |
| Minority interest | 31.65M | 33.20M | 29.39M | 28.59M | — |
Cash flow statement
| 2023 | |
|---|---|
| Operating Activities | |
| Net Income | 37.72M |
| Depreciation | 18.23M |
| Deferred Taxes | — |
| Stock-Based Compensation | -6.09M |
| Other Non-Cash Items | 283,000 |
| Accounts Receivable | -14.30M |
| Accounts Payable | 6.30M |
| Other Assets & Liabilities | 20.59M |
| Operating Cash Flow | 62.74M |
| Investing Activities | |
| Capital Expenditures | -14.56M |
| Net Intangibles | — |
| Net Acquisitions | -985,000 |
| Purchase of Investments | — |
| Sale of Investments | — |
| Investing Cash Flow | -13.44M |
| Financing Activities | |
| Long-Term Debt Issuance | — |
| Long-Term Debt Payments | -272.39M |
| Other Financing Charges | -15.92M |
| Financing Cash Flow | -321.73M |
| Other Cash Details | |
| End Cash Position | 752,000 |
| Income Tax Paid | — |
| Interest Paid | 2.78M |
| Free Cash Flow | 56.26M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Brown Advisory Fds-Brown Advisory Small Cap Fund Value Fd | Nov 30, 2024 | 571,614 | 13.21M | 6.21% |
| Legg Mason Glb Asset Mgt Tr-Clearbridge Small Cap Fd | Oct 31, 2024 | 469,813 | 10.86M | 5.11% |
| Putnam Fds Tr-Putnam Multi Cap Core Fd | Oct 31, 2024 | 449,143 | 10.38M | 4.88% |
| College Retirement Equities Fund-Stock Account | Sep 30, 2024 | 344,170 | 7.95M | 3.74% |
| Guardian VP Tr-Guardian Small Cap Core VIP Fd | Sep 30, 2024 | 98,979 | 2.29M | 1.08% |
| Royce Smaller Companies Growth Fund | Sep 30, 2024 | 75,000 | 1.73M | 0.82% |
| Blackstone Alternative Multi-Strategy Fund | Sep 30, 2024 | 68,082 | 1.57M | 0.74% |
| Calamos Timpani Small Cap Growth Fund | Oct 31, 2024 | 59,938 | 1.39M | 0.65% |
| Driehaus Micro Cap Growth Fund | Sep 30, 2024 | 56,927 | 1.32M | 0.62% |
| Nuveen Small Cap Select Fund | Nov 30, 2024 | 52,904 | 1.22M | 0.58% |
Article
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN) expands to New Jersey through partnership with long-term care pharmacy Freedom Pharmacy.
Dec 17, 2024
Article
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Three Months Ended September 30, 2024 Revenue of $314.4 million, an increase of 20% year-over-year, driven by organic growth of the business and the previously announced acquisition of Heartland Pharmacy completed on April.
Nov 12, 2024
Article
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Stephens Annual Investment Conference, being held in Nashville, on Thursday, November 21, 2024, including a fireside chat at 9:00am CT. The live audio webcast of the fireside chat will be available online at https://investors.guardianpharmacy.com. A replay of the fireside chat will also be availab.
Oct 31, 2024
